Neogen Chemicals posts Q4 FY24 consolidated PAT up 18% at Rs. 16.93 Cr
General

Neogen Chemicals posts Q4 FY24 consolidated PAT up 18% at Rs. 16.93 Cr

The company has reported total income of Rs. 201.86 crores during the period ended March 31, 2024

  • By ICN Bureau | May 02, 2024

Neogen Chemicals Limited has reported consolidated financial results for the period ended March 31, 2024.

Neogen Chemicals has posted net profit of Rs. 16.93 crores for the period ended March 31, 2024 as against net profit of Rs. 1.06 crores for the period ended December 31, 2023. The company posted net profit of Rs.14.31 crores for the period ended March 31, 2023.

The company has reported total income of Rs. 201.86 crores during the period ended March 31, 2024 as compared to Rs. 166.02 crores during the period ended December 31, 2023. The company reported total income of Rs.205.65 crores during the period ended March 31, 2023.

For the Financial Year ended March 31, 2024, Neogen Chemicals has reported total income of Rs.698.14 crores as compared to Rs.690.64 crores during the Financial Year ended March 31, 2023.

The company has posted net profit of Rs.35.65 crores for the Financial Year ended March 31, 2024 as against net profit of Rs.49.97 crores for the Financial Year ended March 31, 2023.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India: Vinayak M. Patankar, Whole Time Director & CEO, Borosil Scientific Ltd. & Sreejith Kumar, Associate Vice President - Design, Borosil Scientific
Aim to become import substitute for instrumentation business in India: Vinayak M. Patankar, Whole Time Director & CEO, Borosil Scientific Ltd. & Sreejith Kumar, Associate Vice President - Design, Borosil Scientific
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Developing new products like Vitamin B1 and Vitamin B6: Hemal Mehta, Chairman, Sudarshan Pharma Industries Ltd. & Sachin Mehta, Managing Director, Sudarshan Pharma Industries
Developing new products like Vitamin B1 and Vitamin B6: Hemal Mehta, Chairman, Sudarshan Pharma Industries Ltd. & Sachin Mehta, Managing Director, Sudarshan Pharma Industries
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.